PT  - JOURNAL ARTICLE
AU  - J. Comin
AU  - D.F. Kallmes
TI  - Dabigatran (Pradaxa)
AID  - 10.3174/ajnr.A3000
DP  - 2012 Mar 01
TA  - American Journal of Neuroradiology
PG  - 426--428
VI  - 33
IP  - 3
4099  - http://www.ajnr.org/content/33/3/426.short
4100  - http://www.ajnr.org/content/33/3/426.full
SO  - Am. J. Neuroradiol.2012 Mar 01; 33
AB  - Summary: Dabigatran (Pradaxa) is a member of the relatively new class of antithrombotic drugs known as direct thrombin inhibitors (DTIs). It may supplant warfarin (Coumadin) in a number of applications as it may produce a more predictable, potent, and immediate anticoagulant effect, with fewer significant side effects and interactions, and requires less monitoring. aPTTactivated partial thromboplastin timeECTEcarin clotting timeINRinternational normalized ratiopGPP-glycoproteinTTthrombin clotting time